| Title : A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan - Chang_2019_Adv.Ther_36_1455 |
| Author(s) : Chang CC , Peng GS , Lai TJ , Li CH , Liu CK |
| Ref : Adv Ther , 36 :1455 , 2019 |
| Abstract : Chang_2019_Adv.Ther_36_1455 |
| ESTHER : Chang_2019_Adv.Ther_36_1455 |
| PubMedSearch : Chang_2019_Adv.Ther_36_1455 |
| PubMedID: 30953330 |
Chang CC, Peng GS, Lai TJ, Li CH, Liu CK (2019)
A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan
Adv Ther
36 :1455
Chang CC, Peng GS, Lai TJ, Li CH, Liu CK (2019)
Adv Ther
36 :1455